Sort
51,593 grants matching “hepatitis”
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders
$442,233Namita Roy-Chowdhury · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Environmental chemical exposures during pregnancy and women's cardio-metabolic health
$442,225Anne Starling · University Of Colorado Denver · R01 · FY2020 · ES
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance
$442,205Jeffrey D Esko · University Of California, San Diego · R01 · FY2012 · GM
IL-17 regulation of type-1 immunity in chronic viral infection
$442,199Mandy J McGeachy · Cornell University · R01 · FY2022 · AI
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$442,177Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development of Pyrimidinedione HIV Inhibitors as Topical Microbicides
$442,156Robert Walter Buckheit · Imquest Biosciences · R44 · FY2007 · AI
VIRAL HEPATITIS INTEGRATION AND INTERVENTION PROJECT
$442,138Alvaro Carrascal · Nysdoh/Health Research, Inc. · U50 · FY2008 · PS
Hemostatic Liver Biopsy Device
$442,046Bioengineering Consultants, Ltd · R44 · FY2001 · DK
Hepatic retinoid metabolism and signaling in starvation and diabetes.
$442,038Natalia Y Kedishvili · University Of Alabama At Birmingham · R01 · FY2024 · DK
Cellular and Synaptic Hypothalamic Reorganization After Exercise Training
$442,034Kevin W Williams · Ut Southwestern Medical Center · P01 · FY2021 · DK
National HIV Behavioral Surveillance System
$441,977Marlene Lalota · Florida State Department Of Health · U1B · FY2012 · PS
Therapeutic Strategies for the Management of HCV/HIV co- infection
$441,974Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2017 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2015 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2014 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2016 · CA
Structural Basis of APOBEC Functions and HIV Restriction
$441,903Xiaojiang S Chen · University Of Southern California · R01 · FY2020 · AI
Role of Hepatic Fatty Acid Oxidation in Metabolic Homeostasis
$441,859Michael J. Wolfgang · Johns Hopkins University · R01 · FY2021 · DK
New In Vitro Human Liver Toxicity Bioassay System
$441,820Raj K. Singh · Vivo Biosciences, Inc. · R44 · FY2012 · ES
MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors
$441,814Andrew Christian Larson · Northwestern University At Chicago · R01 · FY2016 · CA
Innate Control of Hepatitis C Virus Infection: Antiviral and Evasion Mechanisms
$441,802Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2013 · AI
Cyclophilins, Cyclophilin Inhibitors and Hepatitis C
$441,802Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2013 · AI
Role of TLR7 in progression and treatment of alcoholic hepatitis
$441,753Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2018 · AA
FOCUS Data Coordinating Center
$441,748University Of Maryland Baltimore · U01 · FY2005 · HL
Type 1 IFN Function and Signaling in Immunity to Viruses
$441,735Christine A Biron · Brown University · R01 · FY2013 · AI